MGNK — Mologen AG Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €0.06m
- -€2.76m
- €3.05m
Annual income statement for Mologen AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.012 | 0.039 | 0.074 | 0.047 | 3.05 |
| Cost of Revenue | |||||
| Gross Profit | -8.68 | -11 | -11.7 | -9.71 | -3.48 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17.1 | 20.6 | 21.1 | 18.8 | 14.3 |
| Operating Profit | -17.1 | -20.5 | -21 | -18.7 | -11.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -17.1 | -20.5 | -21 | -19.3 | -11.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.1 | -20.5 | -21 | -19.3 | -11.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -17.1 | -20.5 | -21 | -19.3 | -11.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -17.1 | -20.5 | -21 | -19.3 | -11.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.44 | -4.36 | -3.94 | -2.61 | -1.46 |
| Dividends per Share |